Abstract
In an article in this issue of Clinical Cancer Research , Mitsiades et al. ([1][1]) suggest that molecular alterations in thyroid cancer can divert a death receptor–mediated apoptotic pathway into a proliferative response, which poses a serious challenge to treating this cancer effectively by
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
